|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 414.40 NOK | -1.38% |
|
+0.24% | -19.77% |
| 06-02 | DNB Carnegie cuts salmon sector earnings forecasts, Mowi remains top pick - BN | FW |
| 05-20 | Handelsbanken raises Bakkafrost price target to NOK 491 (449), reiterates Hold - BN | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.01 | 7.02 | 4.5 | 3.38 | 2.87 | |||||
Return on Total Capital | 5.89 | 8.34 | 5.31 | 3.98 | 3.4 | |||||
Return On Equity % | 10.67 | 13.62 | 8.99 | 5.86 | 4.72 | |||||
Return on Common Equity | 10.67 | 13.63 | 8.99 | 5.96 | 4.77 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 70.77 | 71.24 | 62.71 | 61.03 | 64.8 | |||||
SG&A Margin | 12.29 | 10.95 | 11.4 | 11.22 | 12.73 | |||||
EBITDA Margin % | 27.88 | 30.89 | 24.54 | 20.9 | 20.91 | |||||
EBITA Margin % | 20.07 | 24.83 | 17.5 | 13.08 | 12.03 | |||||
EBIT Margin % | 20.07 | 24.83 | 17.5 | 13.08 | 12.03 | |||||
Income From Continuing Operations Margin % | 17.36 | 18.85 | 13.38 | 8.79 | 7.47 | |||||
Net Income Margin % | 17.36 | 18.87 | 13.38 | 8.95 | 7.57 | |||||
Net Avail. For Common Margin % | 17.36 | 18.87 | 13.38 | 8.95 | 7.57 | |||||
Normalized Net Income Margin | 12.8 | 14.85 | 10.06 | 7.42 | 5.77 | |||||
Levered Free Cash Flow Margin | -6.66 | -6.19 | -4.73 | 13.63 | -4.7 | |||||
Unlevered Free Cash Flow Margin | -6.2 | -5.65 | -3.14 | 15.33 | -3.27 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.4 | 0.45 | 0.41 | 0.41 | 0.38 | |||||
Fixed Assets Turnover | 1.14 | 1.26 | 1.12 | 1.07 | 0.93 | |||||
Receivables Turnover (Average Receivables) | 10 | 9.98 | 8.61 | 9.62 | 10.2 | |||||
Inventory Turnover (Average Inventory) | 0.54 | 0.57 | 0.63 | 0.69 | 0.61 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.66 | 6.19 | 7.89 | 6.75 | 6.66 | |||||
Quick Ratio | 1.75 | 1.84 | 1.89 | 1.78 | 1.57 | |||||
Operating Cash Flow to Current Liabilities | 1.39 | 1.3 | 1.37 | 3.07 | 1.3 | |||||
Days Sales Outstanding (Average Receivables) | 36.49 | 36.58 | 42.4 | 38.06 | 35.8 | |||||
Days Outstanding Inventory (Average Inventory) | 680.23 | 638.13 | 582.39 | 531.07 | 593.52 | |||||
Average Days Payable Outstanding | 103.84 | 62.12 | 50.45 | 68.79 | 62.52 | |||||
Cash Conversion Cycle (Average Days) | 612.87 | 612.59 | 574.34 | 500.33 | 566.81 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 31.76 | 36.97 | 39.96 | 33.87 | 45.67 | |||||
Total Debt / Total Capital | 24.1 | 26.99 | 28.55 | 25.3 | 31.35 | |||||
LT Debt/Equity | 30.82 | 35.94 | 39.35 | 33.29 | 45.23 | |||||
Long-Term Debt / Total Capital | 23.39 | 26.24 | 28.12 | 24.87 | 31.05 | |||||
Total Liabilities / Total Assets | 36.1 | 38.42 | 39.1 | 36.88 | 41.96 | |||||
EBIT / Interest Expense | 27.45 | 28.58 | 6.88 | 4.81 | 5.22 | |||||
EBITDA / Interest Expense | 40.51 | 37.22 | 10.38 | 8.34 | 10.08 | |||||
(EBITDA - Capex) / Interest Expense | 13.04 | 17.28 | 4.54 | 3.19 | 3.05 | |||||
Total Debt / EBITDA | 1.8 | 1.67 | 2.3 | 2.27 | 3.1 | |||||
Net Debt / EBITDA | 1.49 | 1.35 | 2.08 | 1.98 | 2.92 | |||||
Total Debt / (EBITDA - Capex) | 5.61 | 3.59 | 5.27 | 5.93 | 10.26 | |||||
Net Debt / (EBITDA - Capex) | 4.65 | 2.92 | 4.77 | 5.18 | 9.65 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 19.39 | 28.38 | 0.15 | 2.7 | -4.45 | |||||
Gross Profit, 1 Yr. Growth % | 43.78 | 29.23 | -11.84 | -0.05 | 1.45 | |||||
EBITDA, 1 Yr. Growth % | 54.6 | 42.24 | -20.45 | -12.5 | -4.45 | |||||
EBITA, 1 Yr. Growth % | 62.5 | 58.86 | -29.42 | -23.26 | -12.1 | |||||
EBIT, 1 Yr. Growth % | 62.5 | 58.86 | -29.42 | -23.26 | -12.1 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 108.28 | 39.45 | -28.94 | -32.5 | -18.77 | |||||
Net Income, 1 Yr. Growth % | 108.29 | 39.53 | -28.96 | -31.29 | -19.26 | |||||
Normalized Net Income, 1 Yr. Growth % | 81.65 | 48.87 | -32.14 | -24.24 | -25.7 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 108.36 | 39.48 | -29.06 | -31.4 | -19.28 | |||||
Accounts Receivable, 1 Yr. Growth % | 26.58 | 30.38 | 5.14 | -20.64 | 3.69 | |||||
Inventory, 1 Yr. Growth % | 9.14 | 27.08 | 11.75 | -15.05 | 10.56 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 13.49 | 17.24 | 9.01 | 6.34 | 12.91 | |||||
Total Assets, 1 Yr. Growth % | 10.75 | 15.4 | 5.68 | -0.94 | 7.66 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.53 | 21.27 | 7.98 | 4.63 | -1.73 | |||||
Common Equity, 1 Yr. Growth % | 7.08 | 11.18 | 4.53 | 2.79 | -1.1 | |||||
Cash From Operations, 1 Yr. Growth % | 137.26 | 6.87 | -14.9 | 130.26 | -54.2 | |||||
Capital Expenditures, 1 Yr. Growth % | 33.39 | 10.76 | -14.05 | -3.39 | 10.62 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -33.34 | 19.26 | -23.42 | -395.87 | -132.97 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -35.26 | 16.8 | -44.28 | -601.34 | -120.35 | |||||
Dividend Per Share, 1 Yr. Growth % | 40.82 | 94.55 | -13 | -2.99 | -59.12 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.96 | 23.8 | 13.39 | 1.42 | -0.94 | |||||
Gross Profit, 2 Yr. CAGR % | 19.01 | 36.31 | 6.74 | -6.13 | 0.7 | |||||
EBITDA, 2 Yr. CAGR % | 10.2 | 48.29 | 6.37 | -16.57 | -8.56 | |||||
EBITA, 2 Yr. CAGR % | 5.24 | 60.67 | 5.89 | -26.4 | -17.87 | |||||
EBIT, 2 Yr. CAGR % | 5.24 | 60.67 | 5.89 | -26.4 | -17.87 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 9.65 | 70.43 | -0.46 | -30.74 | -25.95 | |||||
Net Income, 2 Yr. CAGR % | 9.08 | 70.48 | -0.44 | -30.13 | -25.51 | |||||
Normalized Net Income, 2 Yr. CAGR % | 6.87 | 64.44 | 0.51 | -28.3 | -24.97 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 1.95 | 70.51 | -0.53 | -30.24 | -25.59 | |||||
Accounts Receivable, 2 Yr. CAGR % | -0.45 | 28.46 | 17.08 | -8.65 | -9.29 | |||||
Inventory, 2 Yr. CAGR % | 13.52 | 17.77 | 19.17 | -2.57 | -3.09 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 12.34 | 15.35 | 13.05 | 7.66 | 9.58 | |||||
Total Assets, 2 Yr. CAGR % | 5.67 | 13.05 | 10.44 | 2.32 | 3.27 | |||||
Tangible Book Value, 2 Yr. CAGR % | 11.06 | 17.85 | 14.44 | 6.29 | 1.4 | |||||
Common Equity, 2 Yr. CAGR % | 5.94 | 9.11 | 7.8 | 3.65 | 0.82 | |||||
Cash From Operations, 2 Yr. CAGR % | 4.17 | 59.24 | -4.64 | 39.98 | 2.69 | |||||
Capital Expenditures, 2 Yr. CAGR % | 26.05 | 21.55 | -2.43 | -8.87 | 3.38 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 0.06 | -10.84 | -4.43 | 50.53 | -1.23 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -2 | -13.04 | -19.32 | 67.14 | 1 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 65.52 | 30.1 | -8.13 | -37.03 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 20.46 | 16.48 | 15.36 | 9.71 | -0.58 | |||||
Gross Profit, 3 Yr. CAGR % | 18.74 | 22.32 | 17.88 | 4.42 | -3.67 | |||||
EBITDA, 3 Yr. CAGR % | 4.05 | 19.99 | 20.49 | -0.33 | -12.71 | |||||
EBITA, 3 Yr. CAGR % | -1.76 | 20.73 | 22.14 | -4.88 | -21.91 | |||||
EBIT, 3 Yr. CAGR % | -1.76 | 20.73 | 22.14 | -4.88 | -21.91 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 0.13 | 18.79 | 27.32 | -12.55 | -26.96 | |||||
Net Income, 3 Yr. CAGR % | 0.13 | 18.41 | 27.33 | -12.02 | -26.68 | |||||
Normalized Net Income, 3 Yr. CAGR % | -1.01 | 19.35 | 22.43 | -8.53 | -27.44 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -6.15 | 13.19 | 27.29 | -12.12 | -26.76 | |||||
Accounts Receivable, 3 Yr. CAGR % | 32.06 | 8.91 | 20.16 | 2.85 | -4.71 | |||||
Inventory, 3 Yr. CAGR % | 20.66 | 17.87 | 15.73 | 6.46 | 1.63 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 21.64 | 13.95 | 13.2 | 10.76 | 9.39 | |||||
Total Assets, 3 Yr. CAGR % | 36.1 | 8.82 | 10.54 | 6.51 | 4.07 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.58 | 14.36 | 14.47 | 11.07 | 3.55 | |||||
Common Equity, 3 Yr. CAGR % | 31.86 | 7.66 | 7.56 | 6.1 | 2.04 | |||||
Cash From Operations, 3 Yr. CAGR % | 7.2 | 5.06 | 29.22 | 27.94 | -3.54 | |||||
Capital Expenditures, 3 Yr. CAGR % | 28.48 | 20.73 | 8.29 | -2.75 | -2.79 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 60.31 | 6.09 | -15.24 | 39.29 | -9.26 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 52.28 | 3.9 | -25.03 | 48.32 | -17.16 | |||||
Dividend Per Share, 3 Yr. CAGR % | -14.59 | - | 33.58 | 17.98 | -29.86 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.64 | 13.59 | 17.58 | 10.21 | 8.54 | |||||
Gross Profit, 5 Yr. CAGR % | 7.08 | 21.99 | 13.78 | 10.03 | 10.68 | |||||
EBITDA, 5 Yr. CAGR % | -2.76 | 21.99 | 4.97 | 3.75 | 7.9 | |||||
EBITA, 5 Yr. CAGR % | -7.53 | 22.89 | 1.23 | -0.96 | 4.21 | |||||
EBIT, 5 Yr. CAGR % | -7.53 | 22.89 | 1.23 | -0.96 | 4.21 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -6.36 | 21.32 | -0.11 | -4.27 | 2.5 | |||||
Net Income, 5 Yr. CAGR % | -6.36 | 21.34 | -0.1 | -4.12 | 2.75 | |||||
Normalized Net Income, 5 Yr. CAGR % | -6.85 | 22.11 | -0.4 | -2.66 | 0.65 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -9.95 | 16.69 | -3.94 | -6.73 | 2.69 | |||||
Accounts Receivable, 5 Yr. CAGR % | 16.26 | 25.24 | 25.85 | 1.51 | 7.38 | |||||
Inventory, 5 Yr. CAGR % | 7.36 | 23.4 | 20.06 | 9.23 | 7.8 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.63 | 18.81 | 18.13 | 11.39 | 11.73 | |||||
Total Assets, 5 Yr. CAGR % | 21.97 | 26.77 | 25.19 | 6.17 | 7.57 | |||||
Tangible Book Value, 5 Yr. CAGR % | 8.87 | 12.61 | 11.5 | 11.06 | 9.05 | |||||
Common Equity, 5 Yr. CAGR % | 21.37 | 23.44 | 21.65 | 6.04 | 4.81 | |||||
Cash From Operations, 5 Yr. CAGR % | 5.77 | -3.79 | 2.3 | 17.84 | 17.87 | |||||
Capital Expenditures, 5 Yr. CAGR % | 10.2 | 14.12 | 15.09 | 7.88 | 6.3 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 3.4 | -9.92 | 30.35 | 22.03 | -9.89 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 3.03 | -11.94 | 18.11 | 25.66 | -15.54 | |||||
Dividend Per Share, 5 Yr. CAGR % | -9.99 | -0.97 | 1.07 | - | -1.12 |
- Stock Market
- Stocks
- BAKKA Stock
- Financials Bakkafrost
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















